Menu Search
Equities

Mentice AB

MN2:DEU

Mentice AB

Actions
  • Price (EUR)2.74
  • Today's Change0.14 / 5.38%
  • Shares traded0.00
  • 1 Year change-26.93%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mentice AB is a Sweden-based medical technology company. It provides software and hardware simulation solutions and related services for endovascular therapies. The Company’s solutions help healthcare professionals acquire, retain, and enhance their procedural skills. The Company’s solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. The Company also covers neurovascular, cardiovascular and peripheral interventions, among others. It is active globally.

  • Revenue in SEK (TTM)254.07m
  • Net income in SEK-25.98m
  • Incorporated1999
  • Employees128.00
  • Location
    Mentice ABOdinsgatan 10GOETEBORG 411 03SwedenSWE
  • Phone+46 313399400
  • Fax+46 313399499
  • Websitehttps://www.mentice.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.